Jane Suh Associate About
Jane Suh is an Investor on the AlleyCorp Healthcare team and spends her time on incubation, identifying new investment opportunities, and supporting portfolio companies. She was previously a Partner at Andreessen Horowitz on the a16z Bio Fund, backing entrepreneurs at the intersection of healthcare, bio and tech. She was on the founding team of the Bio/Healthcare GTM Network group and advised portfolio companies on go-to-market strategy, business development, sales and product marketing. She was trained as a stem cell biologist, and combines her scientific expertise with her experiences in startups, finance and strategic partnerships to transform companies at the intersection of healthcare, bio and tech.
Prior to joining a16z, she led partnerships and marketing initiatives at an early stage healthcare startup, connecting cancer patients to clinical trials using AI technology. She operationalized and managed partnerships with key hospital stakeholders, oncologists, and nurses at the highest ranked cancer hospitals. Before that, she was an investment banker at Broadhaven Capital Partners and executed capital raises and M&A transactions, most notably was the $5.2bn acquisition of Interactive Data Corporation by Intercontinental Exchange.
Jane holds an A.B. in Human Developmental and Regenerative Biology from Harvard University. During her time at Harvard, she worked directly with the VP of GSK’s Regenerative Medicine group on its strategic partnership with the Harvard Stem Cell Institute, interviewing senior executives and key opinion leaders. She has published her
research on global strategic partnerships in regenerative medicine in Cell Press: Trends in Biotechnology.